Osprey Medical, Inc. announced their DyeVertTM technology has been featured in multiple outlets detailing its use in reducing Contrast Induced Acute Kidney Injury (AKI). Strategic partner, GE Healthcare sponsored a special report that was published by Global Business Media outlining steps to reduce AKI including the DyeVertTM System. Additionally, the DyeVert technology was highlighted in two presentations including the Complex Higher-Risk and Indicated Patients (CHIP) congress in Italy, Milan from 15th- 16th October 2021 and the GE sponsored webinar titled `Acute Kidney Injury (AKI) in complex high risk interventional catheter lab procedures' on 20th October 2021.